Z-Phe-Phe-Phe-OH
目录号 : GA23911Z-Phe-Phe-Phe-OH是一种三肽,可作为一种膜融合抑制剂,与细胞膜或病毒包膜相互作用,干扰脂质双层的融合过程,从而阻止病毒进入宿主细胞或抑制细胞间的融合。
Cas No.:57092-52-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Z-Phe-Phe-Phe-OH is a tripeptide that can act as a membrane fusion inhibitor, interacting with the cell membrane or viral envelope, interfering with the fusion process of the lipid bilayer, thereby preventing the virus from entering the host cell or inhibiting cell-to-cell fusion[1, 2]. Z-Phe-Phe-Phe-OH is composed of three phenylalanine (Phe) residues connected in sequence by peptide bonds and has a benzyloxycarbonyl (Z-) protecting group at the N-terminus. Phenylalanine is an aromatic amino acid with a benzyl ring in its side chain, which makes it highly hydrophobic and rigid[3]. The introduction of the benzyloxycarbonyl protecting group provides additional stability to the tripeptide, making it less likely to degrade during the experiment[4]. The molecular formula of this product is C35H35N3O6 and the molecular weight is 593.68.
References:
[1] Zheng C, Zhong Q, Song W, et al. Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy[J]. Advanced Materials, 2023, 35(14): 2206989.
[2] Kong H, Zheng C, Yi K, et al. An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo[J]. Nature Communications, 2024, 15(1): 4267.
[3] Das T, Häring M, Haldar D, et al. Phenylalanine and derivatives as versatile low-molecular-weight gelators: Design, structure and tailored function[J]. Biomaterials science, 2018, 6(1): 38-59.
[4] Bochet C G. Photolabile protecting groups and linkers[J]. Journal of the Chemical Society, Perkin Transactions 1, 2002 (2): 125-142.
Z-Phe-Phe-Phe-OH是一种三肽,可作为一种膜融合抑制剂,与细胞膜或病毒包膜相互作用,干扰脂质双层的融合过程,从而阻止病毒进入宿主细胞或抑制细胞间的融合[1, 2]。Z-Phe-Phe-Phe-OH是由三个苯丙氨酸(Phe)残基通过肽键依次连接而成,并在N-端具有苄氧羰基(Z-)保护基团。苯丙氨酸作为一种芳香族氨基酸,因其侧链中含有苯环,使其具有较强的疏水性和刚性[3]。苄氧羰基保护基的引入为三肽提供了额外的稳定性,使其在实验过程中不易降解[4]。本产品的分子式为C35H35N3O6,分子量为593.68。
Cas No. | 57092-52-1 | SDF | |
分子式 | C35H35N3O6 | 分子量 | 593.68 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.6844 mL | 8.422 mL | 16.8441 mL |
5 mM | 0.3369 mL | 1.6844 mL | 3.3688 mL |
10 mM | 0.1684 mL | 0.8422 mL | 1.6844 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。